{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:52:29Z","timestamp":1769579549200,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death in the world, and about 80% of the cases are associated with hepatitis B or C. Genetic and epigenetic alterations are accumulated over decades of chronic injury and may affect the functioning of tumor suppressor genes and protooncogenes. Studies have evidenced the role of Long non-coding RNAs (LncRNA) with oncogenic or tumor suppressor activities, suggesting a great potential in the treatment, diagnosis or indicator of prognosis in cancer. In this context, the aim of this study was to evaluate the global expression profile lncRNA in hepatic tissue samples with different stages of fibrosis associated with chronic hepatitis C, HCC and normal liver, in order to identify new lncRNAs that could contribute to study the progression of hepatic fibrosis to HCC associated with chronic hepatitis C. RNA-Seq was performed on Illumina NextSeq platform to identify lncRNAs expressed differently in 15 patients with chronic hepatitis C, three patients with HCC and three normal liver specimens. When the pathological tissues (fibrosis and carcinoma) were compared to normal hepatic tissue, were identified 2, 6 e 34 differentially expressed lncRNAs in moderate fibrosis, advanced fibrosis and HCC, respectively. The carcinoma group had the highest proportion of differentially expressed lncRNA (34) and of these, 29 were exclusive in this type of tissue. A heat map of the deregulated lncRNA revealed different expression patterns along the progression of fibrosis to HCC. The results showed the deregulation of some lncRNA already classified as tumor suppressors in HCC and other cancers, as well as some unpublished lncRNA whose function is unknown. Some of these lncRNAs are dysregulated since the early stages of liver injury in patients with hepatitis C, others overexpressed only in tumor tissue, indicating themselves as candidates of markers of fibrosis progression or tumor, with potential clinical applications in prognosis as well as a therapeutic target. Although there are already studies on lncRNA in hepatocellular carcinoma, this is the first study conducted in samples exclusively of HCV-related liver and HCV HCC.<\/jats:p>","DOI":"10.1038\/s41598-020-66881-2","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T10:03:26Z","timestamp":1592474606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Adriana Camargo","family":"Ferrasi","sequence":"first","affiliation":[]},{"given":"Geysson Javier","family":"Fernandez","sequence":"additional","affiliation":[]},{"given":"Rejane Maria Tommasini","family":"Grotto","sequence":"additional","affiliation":[]},{"given":"Giovanni Faria","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Joao","family":"Goncalves","sequence":"additional","affiliation":[]},{"given":"Marina C.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Francisco J.","family":"Enguita","sequence":"additional","affiliation":[]},{"given":"Maria In\u00eas de Moura Campos","family":"Pardini","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"issue":"6","key":"66881_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6), 394\u2013424, https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J Clin."},{"key":"66881_CR2","doi-asserted-by":"publisher","first-page":"421673","DOI":"10.5402\/2012\/421673","volume":"2012","author":"S Waly Raphael","year":"2012","unstructured":"Waly Raphael, S., Yangde, Z. & Yuxiang, C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol. 2012, 421673, https:\/\/doi.org\/10.5402\/2012\/421673 (2012).","journal-title":"ISRN Oncol."},{"key":"66881_CR3","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil). Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria n\u00b0 602, de 26 de junho de 2012. Aprova as Diretrizes Diagn\u00f3sticas e Terap\u00eauticas do C\u00e2ncer de F\u00edgado no adulto. 2012:1\u201319."},{"key":"66881_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix, J. & Reig, M. Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients with Hepatocellular Carcinoma. Gastroenterology. 150, 835\u201353, https:\/\/doi.org\/10.1053\/j.gastro.2015.12.041 (2016).","journal-title":"Gastroenterology."},{"key":"66881_CR5","doi-asserted-by":"publisher","unstructured":"Marrero, J. A. et al. Diagnosis, staging and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology., https:\/\/doi.org\/10.1002\/hep.29913 (2018).","DOI":"10.1002\/hep.29913"},{"issue":"6","key":"66881_CR6","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142(6), 1264\u20131273.e1, https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061 (2012).","journal-title":"Gastroenterology."},{"issue":"4","key":"66881_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C de Martel","year":"2015","unstructured":"de Martel, C., Maucort-Boulch, D., Plummer, M. & Franceschi, S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 62(4), 1190\u2013200 (2015).","journal-title":"Hepatology."},{"issue":"6","key":"66881_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2016.08.004","volume":"151","author":"NA Terrault","year":"2016","unstructured":"Terrault, N. A. et al. HCV TARGET Study Group. Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response. Gastroenterology. 151(6), 1131\u20131140.e5, https:\/\/doi.org\/10.1053\/j.gastro.2016.08.004 (2016).","journal-title":"Gastroenterology."},{"issue":"Suppl 1","key":"66881_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jvh.12248","volume":"21","author":"H Razavi","year":"2014","unstructured":"Razavi, H. et al. The present and future disease burden of hepatitis C virus (HCV) infection with today\u2019s treatment paradigm. J Viral Hepat. 21(Suppl 1), 34\u201359, https:\/\/doi.org\/10.1111\/jvh.12248 (2014).","journal-title":"J Viral Hepat."},{"key":"66881_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-230X-11-91","volume":"11","author":"A Baranova","year":"2011","unstructured":"Baranova, A., Lal, P., Birerdinc, A. & Younossi, Z. M. Noninvasive markers for hepatic fibrosis. BMC Gastroenterol. 11, 91, https:\/\/doi.org\/10.1186\/1471-230X-11-91 (2011).","journal-title":"BMC Gastroenterol."},{"key":"66881_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/gast.2003.50018","volume":"124","author":"MG Ghany","year":"2003","unstructured":"Ghany, M. G. et al. Progression of fibrosis in chronic hepatitis C. Gastroenterol. 124, 97\u2013104 (2003).","journal-title":"Gastroenterol."},{"issue":"3","key":"66881_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.20621","volume":"41","author":"Y Kamegaya","year":"2005","unstructured":"Kamegaya, Y. et al. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology. 41(3), 660\u20137 (2005).","journal-title":"Hepatology."},{"key":"66881_CR13","first-page":"1613","volume":"21","author":"H Okuda","year":"2007","unstructured":"Okuda, H. Hepatocellular carcinoma development in cirrhosis. Best Practice and Research. Clin Gastroenterol. 21, 1613 (2007).","journal-title":"Clin Gastroenterol."},{"key":"66881_CR14","doi-asserted-by":"crossref","unstructured":"Carrilho FJ, Kikuchi L, Branco F, Goncalves CS, Mattos AA; Brazilian HCC Study Group. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Clinics (Sao Paulo). 65(12):1285\u201390 (2010).","DOI":"10.1590\/S1807-59322010001200010"},{"issue":"9","key":"66881_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13238-014-0065-9","volume":"5","author":"M Liu","year":"2014","unstructured":"Liu, M., Jiang, L. & Guan, X. Y. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell. 5(9), 673\u201391, https:\/\/doi.org\/10.1007\/s13238-014-0065-9 (2014).","journal-title":"Protein Cell."},{"issue":"2","key":"66881_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.canlet.2012.01.038","volume":"342","author":"IP Pogribny","year":"2014","unstructured":"Pogribny, I. P. & Rusyn, I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 342(2), 223\u201330, https:\/\/doi.org\/10.1016\/j.canlet.2012.01.038 (2014).","journal-title":"Cancer Lett."},{"issue":"1","key":"66881_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","volume":"15","author":"A Fatica","year":"2014","unstructured":"Fatica, A. & Bozzoni, I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 15(1), 7\u201321, https:\/\/doi.org\/10.1038\/nrg3606 (2014).","journal-title":"Nat Rev Genet."},{"issue":"1","key":"66881_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/23324015.2015.1077591","volume":"1","author":"M Ward","year":"2015","unstructured":"Ward, M., McEwan, C., Mills, J. D. & Janitz, M. Conservation and tissue-specific transcription patterns of long noncoding RNAs. J Hum Transcr. 1(1), 2\u20139 (2015).","journal-title":"J Hum Transcr."},{"issue":"7385","key":"66881_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nature10887","volume":"482","author":"M Guttman","year":"2012","unstructured":"Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature. 482(7385), 339\u201346, https:\/\/doi.org\/10.1038\/nature10887 (2012).","journal-title":"Nature."},{"issue":"43","key":"66881_CR20","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/onc.2011.621","volume":"31","author":"R Spizzo","year":"2012","unstructured":"Spizzo, R., Almeida, M. I., Colombatti, A. & Calin, G. A. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 31(43), 4577\u201387, https:\/\/doi.org\/10.1038\/onc.2011.621 (2012).","journal-title":"Oncogene."},{"issue":"20","key":"66881_CR21","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1093\/nar\/gks776","volume":"40","author":"S Sati","year":"2012","unstructured":"Sati, S., Ghosh, S., Jain, V., Scaria, V. & Sengupta, S. Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci. Nucleic Acids Res. 40(20), 10018\u201331, https:\/\/doi.org\/10.1093\/nar\/gks776 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"66881_CR22","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1016\/j.jmb.2012.11.024","volume":"425","author":"JH Yoon","year":"2013","unstructured":"Yoon, J. H., Abdelmohsen, K. & Gorospe, M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 425(19), 3723\u201330, https:\/\/doi.org\/10.1016\/j.jmb.2012.11.024 (2013).","journal-title":"J Mol Biol."},{"issue":"9","key":"66881_CR23","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1093\/nar\/gkt182","volume":"41","author":"Q Liu","year":"2013","unstructured":"Liu, Q. et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 41(9), 4976\u201387, https:\/\/doi.org\/10.1093\/nar\/gkt182 (2013).","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"66881_CR24","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/onc.2011.621","volume":"31","author":"R Spizzo","year":"2012","unstructured":"Spizzo, R., Almeida, M. I., Colombatti, A. & Calin, G. A. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 31(43), 4577\u201387, https:\/\/doi.org\/10.1038\/onc.2011.621 (2012).","journal-title":"Oncogene."},{"issue":"7","key":"66881_CR25","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/nar\/gkv233","volume":"43","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 43(7), 3478\u201389, https:\/\/doi.org\/10.1093\/nar\/gkv233 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"66881_CR26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/gutjnl-2016-313573","volume":"67","author":"SH Lin","year":"2018","unstructured":"Lin, S. H. et al. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 67(7), 1299\u20131305, https:\/\/doi.org\/10.1136\/gutjnl-2016-313573 (2018).","journal-title":"Gut."},{"issue":"1","key":"66881_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ccell.2017.11.018","volume":"33","author":"KK Huang","year":"2018","unstructured":"Huang, K. K. et al. Tan P. Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. Cancer Cell. 33(1), 137\u2013150.e5, https:\/\/doi.org\/10.1016\/j.ccell.2017.11.018 (2018).","journal-title":"Cancer Cell."},{"issue":"8","key":"66881_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ng.3013","volume":"46","author":"JMJ Weaver","year":"2014","unstructured":"Weaver, J. M. J. et al. OCCAMS consortium. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet. 46(8), 837\u2013843, https:\/\/doi.org\/10.1038\/ng.3013 (2014).","journal-title":"Nat Genet."},{"issue":"7739","key":"66881_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 565(7739), 312\u2013317, https:\/\/doi.org\/10.1038\/s41586-018-0811-x (2019).","journal-title":"Nature."},{"key":"66881_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 24, 289\u2013293 (1996).","journal-title":"Hepatology."},{"issue":"4","key":"66881_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14(4), R36, https:\/\/doi.org\/10.1186\/gb-2013-14-4-r36 (2013).","journal-title":"Genome Biol."},{"issue":"2","key":"66881_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 31(2), 166\u20139, https:\/\/doi.org\/10.1093\/bioinformatics\/btu638 (2015).","journal-title":"Bioinformatics."},{"issue":"12","key":"66881_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol. 15(12), 550 (2014).","journal-title":"Genome Biol."},{"key":"66881_CR34","doi-asserted-by":"publisher","unstructured":"Bindea G et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. Apr 15;25(8):1091\u20133, https:\/\/doi.org\/10.1093\/bioinformatics\/btp101 (2009).","DOI":"10.1093\/bioinformatics\/btp101"},{"issue":"12","key":"66881_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.tcb.2018.05.005","volume":"28","author":"A Sahakyan","year":"2018","unstructured":"Sahakyan, A., Yang, Y. & Plath, K. The Role of Xist in X-Chromosome Dosage Compensation. Trends Cell Biol. 28(12), 999\u20131013, https:\/\/doi.org\/10.1016\/j.tcb.2018.05.005 (2018).","journal-title":"Trends Cell Biol."},{"issue":"1","key":"66881_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-016-0420-1","volume":"35","author":"DL Chen","year":"2016","unstructured":"Chen, D. L. et al. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin Cancer Res. 35(1), 142, https:\/\/doi.org\/10.1186\/s13046-016-0420-1 (2016).","journal-title":"J Exp Clin Cancer Res."},{"issue":"3","key":"66881_CR37","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.18632\/oncotarget.13670","volume":"8","author":"L Ma","year":"2017","unstructured":"Ma, L. et al. Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497\/MACC1 axis in gastric cancer. Oncotarget. 8(3), 4125\u20134135, https:\/\/doi.org\/10.18632\/oncotarget.13670 (2017).","journal-title":"Oncotarget."},{"issue":"5","key":"66881_CR38","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.3892\/ol.2016.5054","volume":"12","author":"R Kobayashi","year":"2016","unstructured":"Kobayashi, R. et al. Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy. Oncol Lett. 12(5), 3066\u20133074 (2016).","journal-title":"Oncol Lett."},{"issue":"5","key":"66881_CR39","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3892\/ijo.2017.4127","volume":"51","author":"R Zhang","year":"2017","unstructured":"Zhang, R. & Xia, T. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis. Int J Oncol. 51(5), 1460\u20131470, https:\/\/doi.org\/10.3892\/ijo.2017.4127 (2017).","journal-title":"Int J Oncol."},{"issue":"55","key":"66881_CR40","doi-asserted-by":"publisher","first-page":"94358","DOI":"10.18632\/oncotarget.21719","volume":"8","author":"Y Du","year":"2017","unstructured":"Du, Y. et al. LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression. Oncotarget. 8(55), 94358\u201394370, https:\/\/doi.org\/10.18632\/oncotarget.21719 (2017).","journal-title":"Oncotarget."},{"issue":"19","key":"66881_CR41","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.7150\/jca.21024","volume":"8","author":"Z Cheng","year":"2017","unstructured":"Cheng, Z. et al. XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429. J Cancer. 8(19), 4106\u20134116, https:\/\/doi.org\/10.7150\/jca.21024 (2017). 6.","journal-title":"J Cancer."},{"issue":"28","key":"66881_CR42","doi-asserted-by":"publisher","first-page":"43256","DOI":"10.18632\/oncotarget.9673","volume":"12;7","author":"YS Huang","year":"2016","unstructured":"Huang, Y. S., Chang, C. C., Lee, S. S., Jou, Y. S. & Shih, H. M. Xist reduction in breast c\u00e2ncer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget. 12;7(28), 43256\u201343266, https:\/\/doi.org\/10.18632\/oncotarget.9673 (2016).","journal-title":"Oncotarget."},{"issue":"4","key":"66881_CR43","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.bbrc.2018.03.104","volume":"15;498","author":"R Zheng","year":"2018","unstructured":"Zheng, R. et al. Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155\/CDX1 axis. Biochem Biophys Res Commun. 15;498(4), 1002\u20131008, https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.104 (2018).","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"66881_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3216-6","volume":"17","author":"S Chang","year":"2017","unstructured":"Chang, S., Chen, B., Wang, X., Wu, K. & Sun, Y. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. BMC Cancer. 17(1), 248, https:\/\/doi.org\/10.1186\/s12885-017-3216-6 (2017).","journal-title":"BMC Cancer."},{"issue":"6","key":"66881_CR45","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1002\/jcb.26540","volume":"119","author":"Q Kong","year":"2018","unstructured":"Kong, Q. et al. LncRNA XIST functions as a molecular sponge of miR-194-5p to regulate MAPK1 expression in hepatocellular carcinoma cell. J Cell Biochem. 119(6), 4458\u20134468, https:\/\/doi.org\/10.1002\/jcb.26540 (2018).","journal-title":"J Cell Biochem."},{"issue":"1","key":"66881_CR46","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","volume":"132","author":"K Panzitt","year":"2007","unstructured":"Panzitt, K. et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 132(1), 330\u201342 (2007).","journal-title":"Gastroenterology."},{"issue":"1","key":"66881_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3892\/or.2013.2850","volume":"31","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 31(1), 358\u201364, https:\/\/doi.org\/10.3892\/or.2013.2850 (2014).","journal-title":"Oncol Rep."},{"issue":"1","key":"66881_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.18632\/oncotarget.6280","volume":"7","author":"Z Lu","year":"2016","unstructured":"Lu, Z. et al. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget. 7(1), 241\u201354, https:\/\/doi.org\/10.18632\/oncotarget.6280 (2016).","journal-title":"Oncotarget."},{"issue":"2","key":"66881_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jcmm.12956","volume":"21","author":"X Yu","year":"2017","unstructured":"Yu, X., Zheng, H., Chan, M. T. & Wu, W. K. HULC: an oncogenic long non-coding RNA in human cancer. J Cell Mol Med. 21(2), 410\u2013417, https:\/\/doi.org\/10.1111\/jcmm.12956 (2017).","journal-title":"J Cell Mol Med."},{"issue":"6","key":"66881_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/MEG.0b013e328306a3a2","volume":"21","author":"IJ Matouk","year":"2009","unstructured":"Matouk, I. J. et al. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol. 21(6), 688\u201392 (2009).","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"31","key":"66881_CR51","doi-asserted-by":"publisher","first-page":"26302","DOI":"10.1074\/jbc.M112.342113","volume":"287","author":"Y Du","year":"2012","unstructured":"Du, Y. et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 287(31), 26302\u201311, https:\/\/doi.org\/10.1074\/jbc.M112.342113 (2012).","journal-title":"J Biol Chem."},{"key":"66881_CR52","doi-asserted-by":"publisher","first-page":"136106","DOI":"10.1155\/2013\/136106","volume":"2013","author":"H Xie","year":"2013","unstructured":"Xie, H., Ma, H. & Zhou, D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013, 136106, https:\/\/doi.org\/10.1155\/2013\/136106 (2013).","journal-title":"Biomed Res Int."},{"issue":"7","key":"66881_CR53","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00432-014-1871-4","volume":"141","author":"H Zheng","year":"2015","unstructured":"Zheng, H. et al. Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma. J Cancer Res Clin Oncol. 141(7), 1195\u2013203, https:\/\/doi.org\/10.1007\/s00432-014-1871-4 (2015).","journal-title":"J Cancer Res Clin Oncol."},{"key":"66881_CR54","doi-asserted-by":"publisher","unstructured":"Wang S et al. LINC01018 confers a novel tumor-suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p. Am J Physiol Gastrointest Liver Physiol, https:\/\/doi.org\/10.1152\/ajpgi.00005.2019 [Epub ahead of print] (2019).","DOI":"10.1152\/ajpgi.00005.2019"},{"key":"66881_CR55","doi-asserted-by":"publisher","unstructured":"Zhang, S. G. et al. Decreased expression of long non-coding RNA LOC728290 in human hepatocellular carcinoma. Oncol Lett. Oct;14(4):4551\u20134556, https:\/\/doi.org\/10.3892\/ol.2017.6776 (2017).","DOI":"10.3892\/ol.2017.6776"},{"issue":"3","key":"66881_CR56","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/CBM-170471","volume":"21","author":"HF Zhang","year":"2018","unstructured":"Zhang, H. F., Li, W. & Han, Y. D. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma. Cancer Biomark. 21(3), 575\u2013582, https:\/\/doi.org\/10.3233\/CBM-170471 (2018).","journal-title":"Cancer Biomark."},{"key":"66881_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2019.02","volume":"450","author":"J He","year":"2019","unstructured":"He, J. et al. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Lett. 450, 98\u2013109, https:\/\/doi.org\/10.1016\/j.canlet.2019.02 (2019).","journal-title":"Cancer Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66881-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:45:31Z","timestamp":1670330731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66881-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66881"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66881-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9886"}}